These results suggest that mildly affected COVID‐19 patients increased their STAT1/STAT2 expression, but not their detectable levels of phosphorylation, while severely affected COVID‐19 patients showed a greater increase of phosphorylation in relation to the increase of total STAT1 expression. The gene discussed is STAT1; the disease is COVID-19.